Follow-The-Filings

Security · featured owners

ONC Beone Medicines Ltd

Health Care SPONSORED ADS Equity as of 2026 Q2 among managers we track

  • 1 exit

ONC (Beone Medicines Ltd) 13F ownership among featured managers we track as of 2026 Q2. Figures are as-filed 13F, not free float.

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 1,100 $327K history

0 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 4 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 17 rows shown

Filed Form Detail Links
4 Period Sep 8, 2026 Filing Doc
4 Period Sep 1, 2026 Filing Doc
4 Period Aug 25, 2026 Filing Doc
4 Period Aug 11, 2026 Filing Doc
4 Period Aug 10, 2026 Filing Doc
4 Period Aug 3, 2026 Filing Doc
4 Period Jul 30, 2026 Filing Doc
4 Period Jul 22, 2026 Filing Doc
4 Period Jul 20, 2026 Filing Doc
4 Period Jul 15, 2026 Filing Doc
4 Period Jul 17, 2026 Filing Doc
4 Period Jul 10, 2026 Filing Doc
4 Period Jul 14, 2026 Filing Doc
4 Period Jul 8, 2026 Filing Doc
4 Period Jun 23, 2026 · 3 forms Filing Doc
4 Period Jun 16, 2026 · 4 forms Filing Doc
4 Period Jun 11, 2026 · 4 forms Filing Doc

Updated 5 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.46B $3.81B $5.34B
Gross profit $2.08B $3.22B $4.67B
Gross margin * 84.5% 84.4% 87.5%
Net income -$881.71M -$644.79M $286.93M
Net margin * -35.9% -16.9% 5.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $4.2B $3.99B $6.23B
Total non-current assets $1.6B $1.93B $1.95B
Total assets $5.81B $5.92B $8.19B
Total current liabilities $1.81B $2.21B $1.83B
Total non-current liabilities $0.458B $0.374B $2B
Total equity $3.54B $3.33B $4.36B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$1.16B -$0.141B $1.13B
Cash from investing $60M -$548.35M -$276.16M
Cash from financing $0.416B $0.193B $1.06B
Net change in cash -$0.689B -$0.547B $1.97B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders